- Thursday, October 13, 2022
9:50 AM – 10:00 AM ET
Morning Roundtable Discussion
9:50 AM – 10:00 AM ET
Morning Roundtable Discussion
10:00 AM – 10:45 AM ET
Psychopharmacology of Psychedelics: What Every Mental Health Clinician Needs to Know
10:00 AM – 10:45 AM ET
Psychopharmacology of Psychedelics: What Every Mental Health Clinician Needs to KnowSpeaker: – Touro University California College of Pharmacy
Kelan Thomas, PharmD, MS, BCPS, BCPP – Touro University California College of Pharmacy ### 1615845###Speaker###Associate Professor of Clinical Sciences###Touro University California College of Pharmacy###Speaker: – Touro University California College of Pharmacy
### 11:00 AM – 11:30 AM ET
Screening, Risk Assessment & Safety Considerations in Psychedelic Therapy: What Does the Science Say?
11:00 AM – 11:30 AM ET
Screening, Risk Assessment & Safety Considerations in Psychedelic Therapy: What Does the Science Say?Speaker: – Novamind, Inc.
Reid Robison, MD – Novamind, Inc. ### 1615846###Speaker###Chief Medical Officer###Novamind, Inc.###Speaker: – Novamind, Inc.
### 11:45 AM – 12:15 PM ET
How to Stay Up to Date on the Peer Review Literature
11:45 AM – 12:15 PM ET
How to Stay Up to Date on the Peer Review LiteratureSpeaker: – Texas Tech - Permian Basin
Rakesh Jain, MD – Texas Tech - Permian Basin ### 513179###Speaker###Clinical Professor###Texas Tech - Permian Basin###Speaker: – Texas Tech - Permian Basin
### 12:30 PM – 1:00 PM ET
State of the State: The Latest Regulatory Updates for Psychedelic Medicine
12:30 PM – 1:00 PM ET
State of the State: The Latest Regulatory Updates for Psychedelic MedicineSpeaker: – McAllister Law Office, PC
Sean McAllister, Attorney – McAllister Law Office, PC ### 1615847###Speaker###Attorney###McAllister Law Office, PC###Speaker: – McAllister Law Office, PC
### 1:15 PM – 2:15 PM ET
What’s Happening in Oregon?
1:15 PM – 2:15 PM ET
What’s Happening in Oregon?Speaker: – Oregon Health Authority/Public Health Division/Center for Health Protection
Angela E. Allbee, EMPA – Oregon Health Authority/Public Health Division/Center for Health Protection ### 1724678###Speaker###Manager, Oregon Psilocybin Services Section ###Oregon Health Authority/Public Health Division/Center for Health Protection###Speaker: – Oregon Health Authority/Public Health Division/Center for Health Protection
### 2:30 PM – 3:30 PM ET
Emerging Best Practices in Ketamine for Mental Health and Addiction
2:30 PM – 3:30 PM ET
Emerging Best Practices in Ketamine for Mental Health and AddictionSpeaker: – Center for Natural Intelligence
Gita Vaid, MD – Center for Natural Intelligence ### 1631533###Speaker###Psychiatrist###Center for Natural Intelligence###Speaker: – Center for Natural Intelligence
### 3:45 PM – 4:45 PM ET
A Patient's Lived Experience
3:45 PM – 4:45 PM ET
A Patient's Lived ExperienceSpeaker: – Portland VA Medical Center-Vancouver
Zach Skiles, PsyD – Portland VA Medical Center-Vancouver ### 1631534###Speaker###Facilitator###Portland VA Medical Center-Vancouver###Speaker: – Portland VA Medical Center-Vancouver
### - Friday, October 14, 2022
10:00 AM – 1:00 PM ET
State of Research in Different Mental Health Disorders
10:00 AM – 1:00 PM ET
State of Research in Different Mental Health DisordersSpeaker: – Columbia University
Speaker: – University of California, San Francisco, School of Nursing
Speaker: – University of California San Francisco
Speaker:
Speaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
Elias Dakwar, MD – Columbia University ### 1615848###Speaker###Associate Professor of Clinical Psychiatry###Columbia University###Speaker: – Columbia University
### @@@ Andrew D. Penn, MS, PMHNP – University of California, San Francisco, School of Nursing ### 513197###Speaker###linical Professor###University of California, San Francisco, School of Nursing###Speaker: – University of California, San Francisco, School of Nursing
### @@@ Robin Carhart-Harris, PhD – University of California San Francisco ### 515631###Speaker###Ralph Metzner Distinguished Professor of Neurology and Psychiatry, and Director of Psychedelics Division, Neuroscape, University of California San Francisco###University of California San Francisco###Speaker: – University of California San Francisco
### @@@ Charles L. Raison, MD ### 513191###Speaker###Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children & Families; Professor, Human Development and Family Studies, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin######Speaker:
### @@@ Rick Doblin, PhD – Multidisciplinary Association for Psychedelic Studies (MAPS) ### 719359###Speaker###Founder and Executive Director###Multidisciplinary Association for Psychedelic Studies (MAPS)###Speaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
### 1:15 PM – 2:15 PM ET
Addressing Negative Psychedelic Experiences
1:15 PM – 2:15 PM ET
Addressing Negative Psychedelic ExperiencesSpeaker:
Speaker: – Fireside Project
Rosalind P. Watts ### 1324912###Speaker###Director, Twelve Trees Integration Ltd######Speaker:
### @@@ Josh S. White, Juris Doctor – Fireside Project ### 1649507###Speaker###Founder and Executive Director###Fireside Project###Speaker: – Fireside Project
### 2:30 PM – 3:30 PM ET
Exploring Psychedelic Microdosing
2:30 PM – 3:30 PM ET
Exploring Psychedelic MicrodosingSpeaker: – Imperial College London
Speaker: – Center for Psychedelic Research, Imperial College London
Speaker: – University of Chicago
David Erritzøe, MD, PhD – Imperial College London ### 1409021###Speaker###Clinical Senior Lecturer in Psychiatry###Imperial College London###Speaker: – Imperial College London
### @@@ Balazs Szigeti, PhD – Center for Psychedelic Research, Imperial College London ### 1649509###Speaker###Research associate###Center for Psychedelic Research, Imperial College London###Speaker: – Center for Psychedelic Research, Imperial College London
### @@@ Harriet De Wit, PhD – University of Chicago ### 1654447###Speaker###Professor, Dept of Psychiatry and Behavioral Neuroscience###University of Chicago###Speaker: – University of Chicago
### 3:45 PM – 4:45 PM ET
Government Funded Research
3:45 PM – 4:45 PM ET
Government Funded ResearchSpeaker: – National Institute on Drug Abuse (NIDA)
Carlos Blanco, MD, PhD – National Institute on Drug Abuse (NIDA) ### 1691616###Speaker###Director of the Division of Epidemiology, Services, and Prevention Research###National Institute on Drug Abuse (NIDA)###Speaker: – National Institute on Drug Abuse (NIDA)
### - Saturday, October 15, 2022
10:00 AM – 10:45 AM ET
On the Horizon: What Happens After FDA Approval
10:00 AM – 10:45 AM ET
On the Horizon: What Happens After FDA ApprovalSpeaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
Ismail L. Ali, J.D. – Multidisciplinary Association for Psychedelic Studies (MAPS) ### 1759441###Speaker###Director, Policy & Advocacy###Multidisciplinary Association for Psychedelic Studies (MAPS)###Speaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
### 11:00 AM – 11:30 AM ET
Who Plays What Roles in Psychedelic Medicine?
11:00 AM – 11:30 AM ET
Who Plays What Roles in Psychedelic Medicine?Speaker: – Psychedelic Medicine Association
Lynn Marie Morski, MD, JD – Psychedelic Medicine Association ### 1276982###Speaker###President###Psychedelic Medicine Association###Speaker: – Psychedelic Medicine Association
### 11:45 AM – 12:15 PM ET
How to Get Trained in Psychedelic Therapy
11:45 AM – 12:15 PM ET
How to Get Trained in Psychedelic TherapySpeaker: – Fluence
Speaker: – Fluence
Speaker: – CIIS Center for Psychedelic Therapies and Research
Elizabeth Nielson, PhD – Fluence ### 1654452###Speaker###Co-Founder and Chief Visionary Officer###Fluence###Speaker: – Fluence
### @@@ Ingmar Gorman, PhD – Fluence ### 1654454###Speaker###Chief Executive Officer & Co-Founder###Fluence###Speaker: – Fluence
### @@@ Laura Pustarfi, PhD (she/her/hers) – CIIS Center for Psychedelic Therapies and Research ### 1807574###Speaker###Associate Director of the Psychedelic-Assisted Therapies and Research Certificate Program###CIIS Center for Psychedelic Therapies and Research###Speaker: – CIIS Center for Psychedelic Therapies and Research
### she/her/hers12:30 PM – 1:30 PM ET
Addressing Access Challenges for Psychedelic Treatments
12:30 PM – 1:30 PM ET
Addressing Access Challenges for Psychedelic TreatmentsModerator: – University of Wisconsin-Madison
Speaker:
Speaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
Speaker: – Enthea Benefits PBC
Charles L. Raison, MD – University of Wisconsin-Madison ### 513191###Moderator###Professor###University of Wisconsin-Madison###Moderator: – University of Wisconsin-Madison
### @@@ Kwasi Adusei, DNP, PMHNP ### 1324913###Speaker###Co-founder of the Psychedelic Society of Western New York######Speaker:
### @@@ Rick Doblin, PhD – Multidisciplinary Association for Psychedelic Studies (MAPS) ### 719359###Speaker###Founder and Executive Director###Multidisciplinary Association for Psychedelic Studies (MAPS)###Speaker: – Multidisciplinary Association for Psychedelic Studies (MAPS)
### @@@ Dan H. Rome, MD – Enthea Benefits PBC ### 1762853###Speaker###Chief Medical Officer###Enthea Benefits PBC###Speaker: – Enthea Benefits PBC
### 1:45 PM – 2:15 PM ET
What's Next for Psychedelics?
1:45 PM – 2:15 PM ET
What's Next for Psychedelics?Speaker: – Private Practice, Austin, Texas
Speaker: – University of California, San Francisco, School of Nursing
Speaker:
Speaker: – Psychedelic Medicine Association
Saundra Jain, MA, PsyD, LPC – Private Practice, Austin, Texas ### 513182###Speaker###Adjunct Clinical Affiliate, University of Texas at Austin School of Nursing; ###Private Practice, Austin, Texas###Speaker: – Private Practice, Austin, Texas
### @@@ Andrew D. Penn, MS, PMHNP – University of California, San Francisco, School of Nursing ### 513197###Speaker###linical Professor###University of California, San Francisco, School of Nursing###Speaker: – University of California, San Francisco, School of Nursing
### @@@ Charles L. Raison, MD ### 513191###Speaker###Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children & Families; Professor, Human Development and Family Studies, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin######Speaker:
### @@@ Lynn Marie Morski, MD, JD – Psychedelic Medicine Association ### 1276982###Speaker###President###Psychedelic Medicine Association###Speaker: – Psychedelic Medicine Association
###